Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8

1 clinical trials · Condition

Record	Firm	Date
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) (NCT04595747)	National Cancer Institute (NCI)	2021-05-03

Every clearance here is in the API, with alerts when new ones post.